Advantages of using a cell separator and metrizamide gradients for human islet purification.

Human islet transplantation has a high rate of failure, often due to primary nonfunction, which suggests that islets are damaged during the processing of the pancreas. The preparation of human islets for transplantation is still a complex process that requires large teams of surgical and laboratory personnel. To overcome this problem, we have adopted the use of the IBM 2991 COBE cell separator and a metrizamide/Ficoll density medium that is easy to prepare. Twenty-seven pancreatic glands have been processed using the COBE cell separator, 23 of which were purified in metrizamide/Ficoll gradients and 4 in bovine serum albumin gradients. The results show an improvement of recovery and viability in these preparations when compared retrospectively with manual gradients. More importantly, the time required for purification was shortened to one fourth the usual time and total processing time is about half as long. Moreover, a team of two laboratory staff was regularly able to prepare islets for transplantation, reducing the separation time from 7 hr to 3.5 hr. We conclude that the automatic cell separator and metrizamide-based separation medium are useful modifications of current islet purification methods.

[1]  R. Pujol-Borrell,et al.  Reevaluation of Autoantibodies to Islet Cell Membrane in IDDM: Failure to Detect Islet Cell Surface Antibodies Using Human Islet Cells as Substrate , 1992, Diabetes.

[2]  I. Conget,et al.  Human islet function after automatic isolation and bovine serum albumin gradient purification. , 1992, Transplantation.

[3]  P. Morris,et al.  A Method for Isolation of Islets of Langerhans from the Human Pancreas , 1984, Diabetes.

[4]  A. Ariza,et al.  Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. , 1994, Journal of immunology.

[5]  S. Baekkeskov,et al.  Studies of the isolation and viability of human islets of Langerhans. , 1988, Transplantation.

[6]  R. Alejandro,et al.  A simple method of staining fresh and cultured islets. , 1988, Transplantation.

[7]  B. Hering,et al.  Clinical Islet Transplantation — Registry Report, Accomplishments in the past and Future Research Needs , 1993, Cell transplantation.

[8]  Camillo Ricordi,et al.  Automated Method for Isolation of Human Pancreatic Islets , 1988, Diabetes.

[9]  R. James,et al.  Bovine serum albumin density gradient isolation of rat pancreatic islets. , 1987, Transplantation.

[10]  G. Remuzzi,et al.  Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? , 1994, The Lancet.

[11]  C. Ricordi.  Quantitative and qualitative standards for islet isolation assessment in humans and large mammals. , 1991, Pancreas.

[12]  J. Lakey,et al.  Cadaver pancreas recovery technique. Impact on islet recovery and in vitro function. , 1994, Transplantation.

[13]  P. Lacy,et al.  Insulin Independence After Islet Transplantation Into Type I Diabetic Patient , 1990, Diabetes.